Evaluation of Regional Ventilation Distribution in Patients Affected by Abdominal Sepsis After Emergent Laparotomy
CHESTOMY
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate regional ventilation distribution in patients admitted to the intensive care unit after emergent laparotomy due to abdominal sepsis. The main question it aims to answer is: • evaluate if patients admitted after an open abdomen strategy have a different regional ventilation distribution compared to patients in which abdomen is closed at the end of the procedure Participants will undergo non-invasive monitoring (esophageal pressure and electrical impedance tomography) and an blood gas analysis samples. Researchers will compare open abdomen group and closed abdomen group to see if the ventilation distribution pattern is different.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2023
CompletedFirst Posted
Study publicly available on registry
February 14, 2023
CompletedStudy Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 14, 2023
February 1, 2023
1.3 years
January 13, 2023
February 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Chest-wall compliance (Ccw) measured using respiratory parameters from the Ventilator
Different chest wall compliance between the two groups measured using the esophageal catheter. Chest wall compliance will be calculated using the data provided from the respiratory monitoring (i.e. esophageal balloon catheter).
Day 0
Chest-wall compliance (Ccw) measured using respiratory parameters from the Ventilator
Different chest wall compliance between the two groups measured using the esophageal catheter. Chest wall compliance will be calculated using the data provided from the respiratory monitoring (i.e. esophageal balloon catheter).
Day 1
Chest-wall compliance (Ccw) measured using respiratory parameters from the Ventilator
Different chest wall compliance between the two groups measured using the esophageal catheter. Chest wall compliance will be calculated using the data provided from the respiratory monitoring (i.e. esophageal balloon catheter).
Day 2
Secondary Outcomes (5)
Regional ventilation distribution measured using Electrical impedance tomography
Day 0
Regional ventilation distribution measured using Electrical impedance tomography
Day 1
Regional ventilation distribution measured using Electrical impedance tomography
Day 2
Mortality in the intensive care unit
Up to 28 days
Infection rate during ICU stay
Up to 28 days
Study Arms (2)
Open Abdomen
OTHERClosed Abdomen
OTHERInterventions
The researches will collect 2 ml of arterial blood using an arterial line already in place for clinical purposes to perform and arterial gas analysis.
The researches will collect 2 ml of arterial blood using a central venous line already in place for clinical purposes to perform a gas analysis.
The researchers will position an esophageal balloon to evaluate esophageal pressure
The researches will assess intrabdominal pressure using the urinary catheter system already in place for clinical purposes .
The researches will evaluate regional ventilation distribution using Electrical impedance tomography at different levels of positive end-expiratory pressure
Eligibility Criteria
You may qualify if:
- Age \> 18 and \< 90 years
- Admitted to the ICU after emergent laparotomy for abdominal sepsis
- Acute respiratory failure
You may not qualify if:
- Controindications to electrical impedance tomography monitoring
- body mass index \> 40 kg/m2
- Haemodinamic instability
- Pneumothorax - Pneumomediastinum
- refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Università degli Studi di Ferraralead
- University of Milancollaborator
Study Sites (1)
Azienda Ospedaliero Universitaria Sant'Anna
Ferrara, 44121, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 13, 2023
First Posted
February 14, 2023
Study Start
February 15, 2023
Primary Completion
May 30, 2024
Study Completion
December 31, 2024
Last Updated
February 14, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share